{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-060029","form_type":"8-K","ticker":"JSPR","cik":"0001788028","company_name":"Jasper Therapeutics, Inc.","filed_at":"2026-05-21T20:01:33+00:00","discovered_at":"2026-05-21T20:02:00.437571+00:00","generated_at":"2026-05-21T20:02:30.971323+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Jasper Therapeutics director Christian Nolet resigns; Svetlana Lucas joins audit committee","bullets":["Christian Nolet resigned from Board and all committees effective May 15, 2026.","Resignation not due to any disagreement with the company's operations, policies or practices.","Board appointed Svetlana Lucas, Ph.D. to the Audit Committee.","No other changes to board composition or officer roles disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-060029","json":"https://secwatch.observer/filing/0001213900-26-060029.json","markdown":"https://secwatch.observer/filing/0001213900-26-060029.md","text":"https://secwatch.observer/filing/0001213900-26-060029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/0001213900-26-060029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/ea0291168-8k_jasper.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T20:02:30.971323+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ea19a77ff0","claim":"Christian Nolet resigned as Director at Jasper Therapeutics, Inc..","evidence_excerpt":"On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/0001213900-26-060029-index.htm","confidence":0.95}],"comparable_filings":[{"accession":"0001477932-26-003559","ticker":"JOB","company_name":"GEE Group Inc.","filed_at":"2026-06-01T20:47:44+00:00","headline":"Darla Moore resigns from GEE Group board effective June 1, 2026, due to other commitments","event_type":"leadership","sec_items":["5.02","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-26-003559","json":"https://secwatch.observer/filing/0001477932-26-003559.json","markdown":"https://secwatch.observer/filing/0001477932-26-003559.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/40570/000147793226003559/0001477932-26-003559-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/40570/000147793226003559/job_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/0001213900-26-060029-index.htm","comparable_excerpt":"On June 1, 2026, GEE Group Inc. (the “Company”) (NYSE American: JOB) issued a press release announcing that Ms. Darla Moore, has resigned as a member of the Board of Directors (the “Board”) and from all committees of the Company’s Board effective June 1, 2026, due to the time requirements necessary for her existing and new business commitments.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/40570/000147793226003559/0001477932-26-003559-index.htm"}},{"accession":"0001534969-26-000028","ticker":"SERA","company_name":"SERA PROGNOSTICS, INC.","filed_at":"2026-06-01T20:44:21+00:00","headline":"Sera Prognostics director Jeff Elliott resigns ahead of annual meeting","event_type":"leadership","sec_items":["5.02","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001534969-26-000028","json":"https://secwatch.observer/filing/0001534969-26-000028.json","markdown":"https://secwatch.observer/filing/0001534969-26-000028.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534969/000153496926000028/0001534969-26-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534969/000153496926000028/sera-20260526.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/0001213900-26-060029-index.htm","comparable_excerpt":"Jeffrey T. Elliott, a member of the Board of Directors (the “Board”) of Sera Prognostics, Inc. (the “Company”), notified the Company of his decision to resign from the Board effective as of June 4, 2026","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1534969/000153496926000028/0001534969-26-000028-index.htm"}},{"accession":"0001681459-26-000035","ticker":"FTI","company_name":"TechnipFMC plc","filed_at":"2026-06-01T20:38:05+00:00","headline":"TechnipFMC appoints Eric D. Mullins to Board of Directors effective June 1, 2026","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.25,"calibrated_materiality_score":0.25,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001681459-26-000035","json":"https://secwatch.observer/filing/0001681459-26-000035.json","markdown":"https://secwatch.observer/filing/0001681459-26-000035.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681459/000168145926000035/0001681459-26-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681459/000168145926000035/fti-20260529.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/0001213900-26-060029-index.htm","comparable_excerpt":"the Board elected Eric Mullins to the Board and appointed Mr. Mullins to the Audit Committee of the Board, effective June 1, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1681459/000168145926000035/0001681459-26-000035-index.htm"}},{"accession":"0001104659-26-067504","ticker":"FUNC","company_name":"FIRST UNITED CORP/MD/","filed_at":"2026-05-28T20:13:16+00:00","headline":"First United appoints Jason B. Rush as Chairman of the Board, effective May 27, 2026","event_type":"leadership","sec_items":["5.02","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-067504","json":"https://secwatch.observer/filing/0001104659-26-067504.json","markdown":"https://secwatch.observer/filing/0001104659-26-067504.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/763907/000110465926067504/0001104659-26-067504-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/763907/000110465926067504/tm2615909d1_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/0001213900-26-060029-index.htm","comparable_excerpt":"Mr. Rush was elected to the Board by the Corporation’s shareholders at the 2026 annual meeting of shareholders held on May 7, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/763907/000110465926067504/0001104659-26-067504-index.htm"}},{"accession":"0001193125-26-245166","ticker":"FBIZ","company_name":"FIRST BUSINESS FINANCIAL SERVICES, INC.","filed_at":"2026-05-28T20:02:01+00:00","headline":"Scott M. Ferris appointed to FBIZ Board, effective June 1, 2026","event_type":"leadership","sec_items":["5.02","7.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-245166","json":"https://secwatch.observer/filing/0001193125-26-245166.json","markdown":"https://secwatch.observer/filing/0001193125-26-245166.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1521951/000119312526245166/0001193125-26-245166-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1521951/000119312526245166/fbiz-20260522.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/0001213900-26-060029-index.htm","comparable_excerpt":"appointed Mr. Scott M. Ferris as a Class III Director to fill the vacancy created by this increase.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1521951/000119312526245166/0001193125-26-245166-index.htm"}},{"accession":"0001104659-26-067031","ticker":"FRST","company_name":"Primis Financial Corp.","filed_at":"2026-05-27T21:19:36+00:00","headline":"Primis Financial elects two new board members; Clagett and Kabbash depart","event_type":"leadership","sec_items":["5.02","5.07","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-067031","json":"https://secwatch.observer/filing/0001104659-26-067031.json","markdown":"https://secwatch.observer/filing/0001104659-26-067031.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325670/000110465926067031/0001104659-26-067031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325670/000110465926067031/tm2615814d1_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/0001213900-26-060029-index.htm","comparable_excerpt":"directors Robert Y. Clagett and Charles A. Kabbash did not stand for re-election at the annual meeting of stockholders held on May 21, 2026","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1325670/000110465926067031/0001104659-26-067031-index.htm"}},{"accession":"0001437749-26-018590","ticker":null,"company_name":"INTEGRAL TECHNOLOGIES INC","filed_at":"2026-05-27T20:37:50+00:00","headline":"Integral Technologies appoints Michael Pruitt to Board of Directors","event_type":"leadership","sec_items":["5.02","9.01"],"materiality_score":0.25,"calibrated_materiality_score":0.25,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018590","json":"https://secwatch.observer/filing/0001437749-26-018590.json","markdown":"https://secwatch.observer/filing/0001437749-26-018590.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1018281/000143774926018590/0001437749-26-018590-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1018281/000143774926018590/itkg20260527_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/0001213900-26-060029-index.htm","comparable_excerpt":"On May 20, 2026, the Board of Directors (the “Board”) of Integral Technologies Inc. (the “Company”) appointed Michael Pruitt to serve as a member of the Board.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1018281/000143774926018590/0001437749-26-018590-index.htm"}},{"accession":"0001213900-26-063573","ticker":"MZYX","company_name":"MOZAYYX Acquisition Corp.","filed_at":"2026-06-01T21:00:14+00:00","headline":"MOZAYYX Acquisition appoints Emma Rose Bienvenu as independent director","event_type":"leadership","sec_items":["5.02"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: executive_change","same SEC item: 5.02","same event type: leadership","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063573","json":"https://secwatch.observer/filing/0001213900-26-063573.json","markdown":"https://secwatch.observer/filing/0001213900-26-063573.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2097376/000121390026063573/0001213900-26-063573-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2097376/000121390026063573/ea0292919-8k_moxayyx.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On May 15, 2026 (the “Notice Date”), Christian Nolet informed the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) that he is resigning from the Board and the committees of the Board on which he serves, effective as of the Notice Date.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026060029/0001213900-26-060029-index.htm","comparable_excerpt":"On May 26, 2026, the Board of Directors (the “ Board ”) of MOZAYYX Acquisition Corp. (the “ Company ”) appointed Emma Rose Bienvenu to serve as an independent director of the Company, effective immediately.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2097376/000121390026063573/0001213900-26-063573-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}